Metropolis Healthcare Limited promoter Ameera Sushil Shah confirmed that neither she nor other promoters and members of the promoter group created any new encumbrance on equity shares during the financial year ended March 31, 2026. The declaration, submitted to the stock exchanges, ensures compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. This disclosure is critical for shareholders as it indicates the stability of the promoter holding structure and the absence of new leverage against these shares for the period.

The filing detailed the shareholding and encumbrance status of all promoters and promoter group members as of March 31, 2026. While the majority of entities reported zero encumbrances, Metz Advisory LLP, a promoter, disclosed that 12,00,000 of its 6,27,64,864 equity shares remain encumbered. This specific encumbrance was previously disclosed and represents the only outstanding charge against the promoter group's holdings.

The declaration was made on behalf of all promoters and members of the promoter group, including entities such as Duru Shah Family Trust and Sushil Shah Family Trust. Ameera Sushil Shah holds 7,27,380 shares, while the Sushil Shah Family Trust holds 1,49,00,980 shares, both with zero encumbrances. The confirmation was digitally signed and submitted to the Audit Committee, BSE Limited, and National Stock Exchange of India Ltd.

Shareholding and Encumbrance Details

The following table outlines the shareholding and encumbrance status of key promoters as of March 31, 2026:

The document explicitly states that apart from the disclosed encumbrance held by Metz Advisory LLP, no other shares held by the promoters or the promoter group are encumbered directly or indirectly. The confirmation provides transparency regarding the financial pledges associated with the company's top ownership.

Metropolis Healthcare has scheduled an analyst and institutional investor meeting for June 08, 2026, as part of the Macquarie Healthcare Tour. The interaction is set to commence at 03:30 p.m. IST and will be conducted as a group meeting. The company confirmed that discussions during the session will be based solely on publicly available information, and no unpublished price sensitive information (UPSI) is intended to be shared.

The disclosure was made pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The schedule was finalized on June 04, 2026, resulting in the intimation being provided at a shorter notice. The company noted that changes to the schedule may occur due to exigencies on the part of the participants, host, or the company.